Investor Relations



We are a leading science and technology company that delivers life-transforming medicines for serious diseases.

Founded by physician-scientists more than 30 years ago, our science-driven approach has resulted in eight FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.

In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.




  • Nov 21

    Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization
  • Nov 16

    Regeneron Included on Dow Jones Sustainability World Index for Second Consecutive Year


  • Piper Sandler 32nd Annual Virtual Healthcare Conference
    Dec 2
    8:00 AM EST
    Dec 2, 2020 | 8:00 AM EST

  • Evercore ISI 3rd Annual HealthCONx Conference
    Dec 1
    10:30 AM EST
    Dec 1, 2020 | 10:30 AM EST